These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14665975)

  • 1. The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats.
    McLaughlin PJ; Winston K; Swezey L; Wisniecki A; Aberman J; Tardif DJ; Betz AJ; Ishiwari K; Makriyannis A; Salamone JD
    Behav Pharmacol; 2003 Dec; 14(8):583-8. PubMed ID: 14665975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
    Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
    Järbe TU; DiPatrizio NV
    Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387.
    McLaughlin PJ; Qian L; Wood JT; Wisniecki A; Winston KM; Swezey LA; Ishiwari K; Betz AJ; Pandarinathan L; Xu W; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2006 Mar; 83(3):396-402. PubMed ID: 16616951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
    McMahon LR
    Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
    Fattore L; Cossu G; Martellotta CM; Fratta W
    Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
    Solinas M; Goldberg SR
    Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detailed analysis of food-reinforced operant lever pressing distinguishes effects of a cannabinoid CB1 inverse agonist and dopamine D1 and D2 antagonists.
    McLaughlin PJ; Winston KM; Swezey LA; Vemuri VK; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2010 Jul; 96(1):75-81. PubMed ID: 20403373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats.
    Sink KS; McLaughlin PJ; Wood JA; Brown C; Fan P; Vemuri VK; Peng Y; Olszewska T; Thakur GA; Makriyannis A; Parker LA; Salamone JD
    Neuropsychopharmacology; 2008 Mar; 33(4):946-55. PubMed ID: 17581535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats.
    Economidou D; Mattioli L; Cifani C; Perfumi M; Massi M; Cuomo V; Trabace L; Ciccocioppo R
    Psychopharmacology (Berl); 2006 Jan; 183(4):394-403. PubMed ID: 16261315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior.
    Sink KS; Vemuri VK; Olszewska T; Makriyannis A; Salamone JD
    Psychopharmacology (Berl); 2008 Mar; 196(4):565-74. PubMed ID: 18004546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A.
    Järbe TU; Lamb RJ; Liu Q; Makriyannis A
    Eur J Pharmacol; 2003 Apr; 466(1-2):121-7. PubMed ID: 12679148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions.
    Salamone JD; McLaughlin PJ; Sink K; Makriyannis A; Parker LA
    Physiol Behav; 2007 Jul; 91(4):383-8. PubMed ID: 17521686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior.
    Randall PA; Vemuri VK; Segovia KN; Torres EF; Hosmer S; Nunes EJ; Santerre JL; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2010 Nov; 97(1):179-84. PubMed ID: 20713079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.
    Darmani NA
    Neuropsychopharmacology; 2001 Feb; 24(2):198-203. PubMed ID: 11120402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food.
    Melis T; Succu S; Sanna F; Boi A; Argiolas A; Melis MR
    Neurosci Lett; 2007 Jun; 419(3):231-5. PubMed ID: 17462824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.
    Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G
    Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats.
    McLaughlin PJ; Winston KM; Limebeer CL; Parker LA; Makriyannis A; Salamone JD
    Psychopharmacology (Berl); 2005 Jul; 180(2):286-93. PubMed ID: 15948012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats.
    Sink KS; Segovia KN; Nunes EJ; Collins LE; Vemuri VK; Thakur G; Makriyannis A; Salamone JD
    Psychopharmacology (Berl); 2009 Oct; 206(2):223-32. PubMed ID: 19588124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.
    Mansbach RS; Rovetti CC; Winston EN; Lowe JA
    Psychopharmacology (Berl); 1996 Apr; 124(4):315-22. PubMed ID: 8739546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.